Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future
The number of published studies on curcuminoids in cancer research, including its lead molecule curcumin and synthetic analogs, has been increasing substantially during the past two decades. Insights on the diversity of inhibitory effects they have produced on a multitude of pathways involved in car...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2023-05-01
|
| Sarja: | Pharmaceutics |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/1999-4923/15/6/1612 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|